Alik Farber, MD

Professor, Surgery

Alik Farber
617.638.8488
75 E. Newton St Collamore Building

Biography

Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.

Other Positions

  • Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University Chobanian & Avedisian School of Medicine
  • Professor, Vascular & Interventional, Radiology, Boston University Chobanian & Avedisian School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Harvard Medical School, MD
  • Brown University, BS

Publications

  • Published on 2/16/2024

    Conte MS, Azene E, Doros G, Gasper WJ, Hamza T, Kashyap VS, Guzman R, Mena-Hurtado C, Menard MT, Rosenfield K, Rowe VL, Strong M, Farber A. Secondary interventions following open versus endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Feb 16. PMID: 38368997.

    Read at: PubMed
  • Published on 2/12/2024

    Nwachuku EC, Farber A. Open Surgical Therapy for Peripheral Artery Disease. Curr Cardiol Rep. 2024 Feb 12. PMID: 38342801.

    Read at: PubMed
  • Published on 2/2/2024

    Kobzeva-Herzog AJ, Levin SR, Young S, McNamara TE, Alonso AG, Farber A, King EG, Siracuse JJ. Assessing Time to Removal of Tunneled Dialysis Catheters after Arteriovenous Access Creation. Ann Vasc Surg. 2024 Feb 02; 102:35-41. PMID: 38377711.

    Read at: PubMed
  • Published on 1/31/2024

    Farber A, Menard MT, Bonaca MP, Bradbury A, Conte MS, Debus ES, Eldrup N, Goodney P, Gupta PC, Hinchliffe RJ, Houlind KC, Kolh P, Kum SWC, Nordanstig J, Parikh SA, Patel MR, Patrone L, Sillesen H, Strong MB, Varcoe RL, Vega de Ceniga M, Venermo MA, Rosenfield K. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally. Br J Surg. 2024 Jan 31; 111(2). PMID: 38294083.

    Read at: PubMed
  • Published on 1/30/2024

    Forsyth A, Haqqani MH, Alfson DB, Shaikh SP, Brea F, Richman A, Siracuse JJ, Rybin D, Farber A, Brahmbhatt TS. Long-term outcomes of autologous vein bypass for repair of upper and lower extremity major arterial trauma. J Vasc Surg. 2024 Jan 30. PMID: 38301809.

    Read at: PubMed
  • Published on 1/17/2024

    Smeds MR, Cheng TW, King E, Williams M, Farber A, Chitalia VC, Siracuse JJ. Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access. J Vasc Surg. 2024 Jan 17. PMID: 38237702.

    Read at: PubMed
  • Published on 12/16/2023

    Zhu M, Arinze N, Buitron de la Vega P, Alonso A, Levin S, Farber A, King E, Kobzeva-Herzog A, Chitalia VC, Siracuse JJ. High Prevalence of Adverse Social Determinants of Health in Dialysis Access Creation Patients in a Safety-Net Setting. Ann Vasc Surg. 2024 Mar; 100:31-38. PMID: 38110081.

    Read at: PubMed
  • Published on 12/5/2023

    Farber A, Siracuse JJ, Giles K, Jones D, Laskowski IA, Powell RJ, Rosenfield K, Strong MB, White CJ, Doros G, Menard MT. Investigator attitudes on equipoise and practice patterns in the BEST-CLI trial. J Vasc Surg. 2023 Dec 05. PMID: 38056700.

    Read at: PubMed
  • Published on 11/20/2023

    Yahn C, Haqqani MH, Alonso A, Kobzeva-Herzog A, Cheng TW, King EG, Farber A, Siracuse JJ. Long-term functional outcomes of upper extremity civilian vascular trauma. J Vasc Surg. 2024 Mar; 79(3):526-531. PMID: 37992948.

    Read at: PubMed
  • Published on 10/6/2023

    Haqqani MH, Kester LP, Lin B, Farber A, King EG, Cheng TW, Alonso A, Garg K, Eslami MH, Rybin D, Siracuse JJ. Outcomes of lower extremity revascularization in octogenarians and nonagenarians for intermittent claudication. J Vasc Surg. 2023 Dec; 78(6):1479-1488.e2. PMID: 37804952.

    Read at: PubMed

View 340 more publications: View full profile at BUMC

View all profiles